{"address1": "No. 258, Liancheng Road", "address2": "16th Floor-1 Zhonghe District", "city": "New Taipei City", "zip": "235", "country": "Taiwan", "phone": "886 2 8221 3985", "fax": "886 2 8227 2168", "website": "https://www.liwanli.com.tw", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "LIWANLI Innovation Co., Ltd. operates in the biomedical science industry. It provides products in the areas of nutrition and healthcare. The company offers Vigoway and powder collection products for male, female, elderly, and children audience. Its products include probiotic enzymes, pro-active nutrients, resveratrol red grape extract, algae DHA soft gels, shea butter with type II collagen soft gels, algae astaxanthin Q10 soft gels, cordyceps militaries powder, tooth guard tablets, bovine and goat's milk bites, bilberry-tablets, DHA and vitamin D3 drops, and other products. The company was formerly known as Carry Technology International Co., Ltd. and changed its name to LIWANLI Innovation Co., Ltd. in 2015. LIWANLI Innovation Co., Ltd. was founded in 1980 and is based in New Taipei City, Taiwan.", "maxAge": 86400, "priceHint": 2, "previousClose": 19.25, "open": 18.5, "dayLow": 18.5, "dayHigh": 19.0, "regularMarketPreviousClose": 19.25, "regularMarketOpen": 18.5, "regularMarketDayLow": 18.5, "regularMarketDayHigh": 19.0, "exDividendDate": 1530144000, "payoutRatio": 0.0, "beta": 0.058923, "volume": 12000, "regularMarketVolume": 12000, "averageVolume": 28704, "averageVolume10days": 16406, "averageDailyVolume10Day": 16406, "bid": 18.7, "ask": 18.9, "bidSize": 0, "askSize": 0, "marketCap": 1528305024, "fiftyTwoWeekLow": 18.15, "fiftyTwoWeekHigh": 23.75, "priceToSalesTrailing12Months": 44.96602, "fiftyDayAverage": 19.127, "twoHundredDayAverage": 19.3495, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "TWD", "enterpriseValue": 1151411584, "profitMargins": 0.0, "sharesOutstanding": 80651000, "heldPercentInsiders": 0.81867, "heldPercentInstitutions": 0.0, "impliedSharesOutstanding": 0, "bookValue": 9.49, "priceToBook": 1.9915701, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1672444800, "netIncomeToCommon": -120907000, "trailingEps": -1.07, "lastSplitFactor": "743.3393:1000", "lastSplitDate": 1536796800, "enterpriseToRevenue": 33.877, "enterpriseToEbitda": -32.253, "52WeekChange": 0.032171607, "SandP52WeekChange": 0.026524067, "lastDividendValue": 0.538112, "lastDividendDate": 1530144000, "exchange": "TAI", "quoteType": "EQUITY", "symbol": "3054.TW", "underlyingSymbol": "3054.TW", "shortName": "LIWANLI INNOVATION CO LTD", "longName": "LIWANLI Innovation Co., Ltd.", "firstTradeDateEpochUtc": 1037667600, "timeZoneFullName": "Asia/Taipei", "timeZoneShortName": "CST", "uuid": "f570dca8-ef86-38c7-ba29-f16e94e5bbd1", "messageBoardId": "finmb_7612670", "gmtOffSetMilliseconds": 28800000, "currentPrice": 18.9, "recommendationKey": "none", "totalCash": 386295008, "totalCashPerShare": 4.79, "ebitda": -35699000, "totalDebt": 1305000, "quickRatio": 11.376, "currentRatio": 11.821, "totalRevenue": 33988000, "debtToEquity": 0.171, "revenuePerShare": 0.421, "returnOnAssets": -0.02861, "returnOnEquity": -0.14542, "grossProfits": 11393000, "freeCashflow": -30628250, "operatingCashflow": 78479000, "revenueGrowth": -0.021, "grossMargins": 0.33521, "ebitdaMargins": -1.0503399, "operatingMargins": -1.18115, "financialCurrency": "TWD", "trailingPegRatio": null}